Effectiveness of pharmacotherapy in asthmatic preschool children

Allergy: European Journal of Allergy and Clinical Immunology, Supplement

Volumn 57, Issue 74, 2002, Pages 42-47

  De Jongste, J C ^a   Janssens, H M ^a   Van Der Wouden, J ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Asthma; Children; Compliance; Effectiveness; Pharmacotherapy; Preschool

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIHISTAMINIC AGENT; ANTIINFLAMMATORY AGENT; ANTITUSSIVE AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; KETOTIFEN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; NITRIC OXIDE; STEROID; THEOPHYLLINE DERIVATIVE;

ARTICLE; ASTHMA; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; FACE MASK; HUMAN; INTERMETHOD COMPARISON; LONG TERM CARE; MEDICAL DECISION MAKING; METERED DOSE INHALER; PARENTAL BEHAVIOR; PATIENT COMPLIANCE; PHENOTYPE; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT INDICATION; WHEEZING;

ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD WELFARE; CHILD, PRESCHOOL; CLINICAL TRIALS; HUMANS; NEBULIZERS AND VAPORIZERS; PATIENT COMPLIANCE; PRACTICE GUIDELINES; TREATMENT OUTCOME;

EID: 0036033429     PISSN: 01081675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Warner JO, Götz M, Landau LI, et al. Management of asthma: A consensus statement. Arch Dis Child 1989;64: 1065-1079.
2. Warner JO. Asthma: A follow up statement from an international paediatric asthma consensus group. Arch Dis Child 1992;67:240-248.
3. Warner JO, Naspitz CK, Cropp GJA, eds. Third international pediatric consensus statement on the management of childhood asthma. Pediatr Pulmonol 1998;25:1-17.
4. Woodhead M, ed. Guidelines on the management of asthma. Statement by the British Thoracic Society, the British Paediatric Association, the Research Unit of the Royal College of Physicians of London, the King's Fund Centre, The National Asthma Campaign, the Royal College of General Practitioners, the General Practitioners in Asthma Group, the British Association of Accident and Emergency Medicine, and the British Paediatric Respiratory Group Following a Meeting at the Royal College of Physicians, London. 4 and 5 June 1992. Thorax. 1993;48:S1-S24.
5. Hoekstra MO. Behandeling van astma bij kinderen; herziene richtlijnen van kinderlongartsen, Ned Tijdschr Geneeskd 1997;141:2223-2228.
6. Silverman M, Wilson N. Wheezing phenotypes in childhood. Thorax 1997;52:936-937.
7. Keeley DJ, Silverman M. Issues at the interface between primary and secondary care in the management of common respiratory disease 2. Thorax 1999;544:625-628.
8. Seear M, Wensley D. Chronic cough and wheeze in children: Do they all have asthma? Eur Respir J 1997;10:342-345.
9. Martinez FD, Wright AL, Taussig LM, et al. For the Group Health Medical Associates. Asthma and wheezing in the first six years of life. N Engl J Med 1995;332:133-138.
10. Martinez FD, Morgan WJ, Wright AL, et al. For the Group Health Medical Associates. Initial airway function is a risk factor for recurrent wheezing respiratory illnesses during the first three years of life. Am Rev Respir Dis 1991;143:312-316.
11. Young S, Arnott J, O'Keeffe PT, et al. The association between early life lung function and wheezing during the first 2 yrs of life. Eur Respir J 2000;15:151-157.
12. Stevenson EC, Turner G, Heaney LG, et al. Bronchoalveolar lavage findings suggest two different forms of childhood asthma. Clin Exp Allergy 1997;27:1027-1035.
13. Nelson BV, Sears S, Woods J, et al. Expired nitric oxide as a marker for childhood asthma. J Pediatr 1997;130:423-427.
14. American Thoracic Society. Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children. Am J Respir Crit Care Med 1999;160:2104-2117.
15. Baraldi E, De Jongste JC, On Behalf of the Task Force. ERS/ATS statement. Measurement of exhaled nitric oxide in children, 2001. Eur Respir J 2002;20:223-237.
16. Jatakanon A, Lim S, Kharitonov SA, et al. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998;53:91-95.
17. Piacentini GL, Bodini A, Costella S, et al. Exhaled nitric oxide and sputum eosinophil markers of inflammation in asthmatic children. Eur Respir J 1999;13:1386-1390.
18. Little SA, Chalmers GW, MacLeod KJ, et al. Non-invasive markers of airway inflammation as predictors of oral steroid responsiveness in asthma. Thorax 2000;55:232-234.
19. Jöbsis Q, Schellekens SL, Kroesbergen A, et al. Sampling of exhaled nitric oxide in children: Endexpiratory plateau, balloon and tidal breathing methods cornpard. Eur Respir J 1999;13:1406-1410.
20. Baraldi E, Dario C, Ongaro R, et al. Exhaled nitric oxide concentrations during treatment of wheezing exacerbation in infants and young children. Am J Respir Crit Care Med 1999;159: 1284-1288.
21. Frank TI, Adisesh A, Pickering AC, et al. Relationship between exhaled nitric oxide and childhood asthma. Am J Respir Crit Care Med 1998;158:1032-1036.
22. De Jongste JC, Alving K. Gas analysis. Am J Respir Crit Care Med 2000;162: S23-27.
23. Ingram JM, Rakes GP, Hoover GE, et al. Eosionphil cationic protein in serum and nasal washes from wheezing infants and children. J Pediatr 1995;127: 558-564.
24. Lødrup Carlsen KC, Halvorsen R, Ahlstedt S, Carlsen K-H. Eosinophil cationic protein and tidal flow volume loops in children 0-2 years of age. Eur Respir J 1995;8:1148-1154.
25. Jöbsis Q, Raatgeep HC, Hermans PWM, De Jongste JC. Hydrogen peroxide in exhaled air is increased in stable asthmatic children. Eur Respir J 1997;10:519-521.
26. Jöbsis Q, Raatgeep HC, Schellekens SL, et al. Hydrogen peroxide in exhaled air of healthy children: Reference values. Eur Respir J 1998;12:483-485.
27. Martinez FD, Stern DA, Wright AL, et al. For the Group Health Medical Associates. Association of nonwheezing lower respiratory tract illnesses in early life with persistently diminished serum IgE levels. Thorax 1995;50: 1067-1072.
28. Clough JB, Keeping KA, Edwards LC, et al. Can we predict which wheezy infants will continue to wheeze? Am J Respir Crit Care Med 1999;160: 1473-1480.
29. Tasche MJA, Van Der Wouden JC, Uijen JHJM, et al. Randomised placebo-controlled trial of inhaled sodium cromoglycate in 14-year-old children with moderate asthma. Lancet 1997;350:1060-1064.
30. Janssens HM, Devadason SG, Hop WCJ, et al. Vaiability of aerosol delivery via spacer devices in young asthmatic children in daily life. Eur Respir J 1999;13:787-791.
31. Volovitz B, Tabachnik E, Nussinovitch M, et al. Montelukast, a leukotriene receptor antagonist, reduces the concentration of leukotrienes in the respiratory tract of children with persistent asthma. J Allergy Clin Immunol 1999;104: 1162-1167.
32. Knorr B, Matz J, Bernstein JA, et al. For the Pediatric Montelukast Study Group. Montelukast for chronic asthma in 6-14-year-old children: A randomized, double-blind trial. JAMA 1998;279:1181-1186.
33. Knorr B, Franchi LM, Bisgaard H, et al. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Pediatrics 2001;108:e48.
34. Tasche MJA, Uijen JHJM, Berndsen RMD, et al. Inhaled disodium cromoglycate (DSCG) as maintenance therapy in children with asthma: A systematic review. Thorax 2000;55:913-920.
35. Cogswell JJ, Simpkiss MJ. Nebulised sodium cromoglycate in recurrently wheezy preschool children. Arch Dis Child 1985;60:736-738.
36. De Baets F, Van Daele S, Franckx H, Vinaimont F. Inhaled steroids compared with disodium cromoglycate in preschool children with episodic viral wheeze. Pediatr Pulmonol 1998;25: 361-366.
37. Furfaro S, Spier S, Drblik SP, et al. Efficacy of cromoglycate in persistently wheezing infants. Arch Dis Child 1994;71:331-334.
38. Canny GJ, Reisman J, Levison H. Does ketotifen have a steroid-sparing effect in childhood asthma? Eur Respir J 1997;10:65-70.
39. Cockcroft DW, Keshmiri M, Murdock KY, Gore BC. Allergen-induced increase in airway responsiveness is not inhibited by acute treatment with ketotifen or clemastine. Ann Allergy 1992;68:245-250.
40. Graff-Lonnevig V, Hedlin G. The effect of ketotifen on bronchial hyperreactivity in childhood asthma. J Allergy Clin Immunol 1985;76:59-63.
41. Volovitz B, Varsano I, Cumella JC, Jaber L. Efficacy and safety of ketotifen in young children with asthma. J Allergy Clin Immunol 1988;81:526-530.
42. Loftus BG, Price JF. Long-term, placebo-controlled trial of ketotifen in the management of preschool children with asthma. J Allergy Clin Immunol 1987;79:350-355.